Order of the National Green Tribunal in the matter of News Item titled "2 killed in blast at illegal cracker unit in Thanjavur appearing in The Hindu dated 19.05.2025". The application is registered suo-motu on the basis of the news item titled 2 killed in blast at illegal cracker unit …
Hundreds of Japanese people accidentally infected with hepatitis C between the 1970s and 1990s are to be awarded compensation from the government and the drug companies responsible. But thousands of others also affected by the scandal stand to get nothing.
DEBATE Eventually, the debate boils down to whether removing patent rights will lead to lower R&D; in diseases that are important for patients in developing economies. Ranjit Shahani Vice-Chairman & Managing Director, Novartis India Limited If people don't get a fair return in innovation, they won't invest in finding new …
Pfizer Inc, the world's largest pharmaceutical company, will soon initiate programmes to develop drugs specific to diseases in developing countries, such as India, moving away from its history of focusing on ailments prevalent in the US and Europe. "Our drug development activities in future will include drugs specific to regional …
With global pharma companies waking up to technology outsourcing services as a tool to reduce the time to market of their R&D; harvest, Accenture is looking at expanding the scope and scale of its lifescience centre of excellence in India. Accenture's life science R&D; centre in Bangalore is its largest …
What do many pharmaceutical companies across the world do when the number of new molecules that get past human clinical trials and the regulatory approval process is in steady decline? They cash in on drugs that manage to pass all the hurdles and milk them even after the patent expires …
The International Partnership for Microbicides (IPM) has signed an agreement with pharmaceutical company Pfizer under which the pharma major will give IPM a royalty-free license to use maraviroc, its newly approved HIV treatment, as a microbicide for the prevention of HIV infection. Maraviroc is one of a new class of …
Philippines recently ordered Novartis to pull out its anti-arthritis painkiller from the country. It is feared that the drug lumiracoxib, also sold as prexige, causes liver damage. The Bureau of Food and Drugs, the health regulators in the country, said the risks were greater than the benefits and cited reports …
a patent dispute between pharma companies over a migrane drug in the us market has been settled out of court. Ranbaxy, one of the world's largest producers of generic drugs, announced through a press release on January 21 an out-of-court settlement with international pharmaceutical giant GlaxoSmithKline (gsk) over the migrane …
Mumbai-based Sun Pharmaceuticals has filed a post-grant opposition with the Mumbai patent office against a product patent granted to the extended release version of Johnson and Johnson's (J&J;) blockbuster drug Risperdal, used in the treatment of psychological disorders and schizophrenia. Risperdal, with the molecular name risperidone, is the second-largest selling …
Even as India is fast turning into the diabetes capital of the world, multinational drug companies are busy patenting new-generation diabetes medicines for exclusive marketing rights in the country. The Indian Patent Office has already awarded patents to at least three such products, say patent experts. Though the immediate impact …
For years the global malaria effort has been asking for more resources.Now the field needs to figure out a systematic strategy for spending the money effectively.
R&D; is a fast evolving segment of Indian pharmaceutical industry. Innovation, international partnerships, collaborations, inflow of funds, clinical trials partnerships and co-development deals are changing the landscape of R&D.; However, the potential is far greater and to aid the harnessing of this potential, the Times Group organised the ET Bio-Pharma …
THE public-private partnership model is now catching up in the drug R&D; as well. In a first-ofits-kind partnership, the Rs 3,000-crore Nicholas Piramal Group on Friday signed an agreement with department of biotechnology (DBT) to jointly screen for biomolecules from microbes. The project cost is Rs 25 crore, of which …
Novartis, the Swiss pharmaceutical group, is stepping up the case for use of its experimental pandemic flu vaccine even ahead of a new virus mutation that could trigger a future lethal outbreak in humans. Jorg Reinhardt, head of vaccines and diagnostics, said the company would publish scientific data showing that …
India has performed poorly in international patent filings last year compared to its neighbour China, according to data released by the Geneva-based World Intellectual Property Organisation (WIPO). Filing patent applications under WIPO's Patent Cooperation Treaty (PCT) enables companies to secure patent protection in various countries. It is a measure for …
The Biotechnology Industry Association (BIA), the representative body of international biotech product makers, has expressed concern over the patent criteria norms prescribed under the Indian Patent Act. In a representation to the office of the US Trade Representative (USTR) on February 11, the association has demanded that India be kept …
The Canadian health and drug regulator Health Canada has asked Ranbaxy Pharmaceuticals Canada (RPCI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL) to withdraw its generic, 25 microgram per hour strength, fentanyl pain-relief patches from the Canadian market due to safety concerns. Ranbaxy controls more than 50 per cent …
india is set to make another round of changes in procurement norms for health schemes funded by World Bank loans. This follows the bank's review of Indian projects running on its loans, highlighting corrupt practices in procurement of drugs and other items by the government and drug companies. While such …
The government must encourage the manufacture of cheaper drugs which will benefit the consumer. Till the early 1980's, dominant foreign companies dominated pharmaceutical manufacturing in India. Today the dominant ones are Indian owned. The then Indian patent laws helped this transformation. Until recently India recognised only process patents. Reverse engineering …
